. Author manuscript; available in PMC: 2021 Feb 1.

Published in final edited form as: Int Forum Allergy Rhinol. 2019 Oct 10;10(2):183–189. doi: 10.1002/alr.22454

TABLE 1.

Demographics of patients included in the study

	CRSwNP NOS	AERD	AFRS	CCAD	CRSwNP/CC	p Value
Patients [n (%)]	132 (37.1%)	86 (24.2%)	84 (23.6%)	41 (11.5%)	13 (3.7%)
Age, mean (years)	56.1	48.9	36	46.5	50.9	p < 0.001^a
Female [n (%)]	57 (43.2%)	48 (55.8%)	34 (40.5%)	17 (41.5%)	5 (38.5%)	p = 0.462
Race [n (%)]
Caucasian	87 (66%)	44 (51.2%)	30 (35.7%)	17 (41.5%)	5 (38.5%)
African American	36 (27.2%)	34 (40%)	44 (52.3%)	20 (48.8%)	6 (46.1%)
Other	8 (6%)	3 (3%)	1 (1.2%)	3 (7.3%)	1 (7.7%)
Unknown	1 (0.8%)	5 (5.8%)	9 (10.8%)	1 (2.4%)	1 (7.7%)

Statistically significant difference between groups.

AERD = aspirin-exacerbated respiratory disease; AFRS = allergic fungal rhinosinusitis; CCAD = isolated central compartment atopic disease; CRSwNP NOS = chronic rhinosinusitis with nasal polyposis, not otherwise specified; CRSwNP/CC = patients with central compartment and sinonasal polyps.